Alterations of the tumor microenvironment in glioblastoma following radiation and temozolomide with or without bevacizumab

BACKGROUND: The immunosuppressive tumor microenvironment (TME) contributes to the tumor progression and treatment failure. Our previous study demonstrated alterations in the TME during bevacizumab (Bev) therapy in human glioblastoma (GB) specimens obtained from patients who underwent surgical resect...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Ryota, Tanaka, Toshihide, Morimoto, Yukina, Kuranari, Yuki, Yamamoto, Yohei, Takei, Jun, Murayama, Yuichi, Yoshida, Kazunari, Sasaki, Hikaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186631/
https://www.ncbi.nlm.nih.gov/pubmed/32355741
http://dx.doi.org/10.21037/atm.2020.03.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186631/
https://www.ncbi.nlm.nih.gov/pubmed/32355741
http://dx.doi.org/10.21037/atm.2020.03.11

Ejemplares similares